MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor–1
The oncoprotein transcription factor MYC is a major driver of malignancy and a highly validated but challenging target for the development of anticancer therapies. Novel strategies to inhibit MYC may come from understanding the co-factors it uses to drive pro-tumorigenic gene expression programs, pr...
| 主要な著者: | , , , , , , , , , , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
eLife Sciences Publications Ltd
2021-01-01
|
| シリーズ: | eLife |
| 主題: | |
| オンライン･アクセス: | https://elifesciences.org/articles/60191 |